Quel est le prix pour Silo Pharma, Inc. (SILO)

Le prix pour Silo Pharma, Inc. (SILO) est $3.29

Quelle est la capitalisation boursière pour Silo Pharma, Inc. (SILO)

La capitalisation boursière pour Silo Pharma, Inc. (SILO) est $3.71M

Silo Pharma, Inc. (SILO) Prix et Capitalisation Boursière

Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.

Prix pour SILO	L’actif B	La capitalisation boursière de B	Résultats
$4,830,422 $3.71M	NVDA	$5.452T	+146,821,240.26%
$3,978,213 $3.71M	AAPL	$4.490T	+120,918,236.84%
$3,687,944 $3.71M	GOOG	$4.162T	+112,095,461.94%
$3,257,285 $3.71M	MSFT	$3.676T	+99,005,516.16%
$2,510,111 $3.71M	AMZN	$2.833T	+76,295,058.95%

Prix pour SILO

L’actif B

La capitalisation boursière de B

Résultats

$4,830,422 $3.71M